Related Links:
For additional information about ROX Medical, please refer to the following links.
- OC Register – ROX raises third round funding...
- The WALK Trial is registered at clinicaltrials.gov
Rodney Brenneman, President and CEO
BS in Mechanical Engineering, San Diego State University
Mr. Brenneman has 24 years experience in the medical device industry. He co-founded ROX Medical in 2004. Prior to ROX Medical Mr. Brenneman worked for USGI Medical as Vice President of R&D. At USGI he led a team of nine engineers and technicians to develop devices for endo-luminal GI surgery. Mr. Brenneman co-founded TheraCardia in 1998 and served as VP of R&D and Operations until 2003. Prior to 1998, Mr. Brenneman worked for Vesica Medical, acquired by Boston Scientific, Corp in 1996 and Advanced Surgical Intervention acquired by Boston Scientific, Corp in 1993. Mr. Brenneman has also done considerable consulting for very early stage medical device companies in a wide variety of specialties including Cardiology, Orthopedics, Urology, Opthamology, Neurology and Interventional Radiology.
Martin Chambers, Global Vice President of Sales
Mr. Chambers has significant experience in both Sales and Marketing, through numerous international management assignments, within three different continents, Europe, Asia Pacific and North America. Prior to joining Rox Medical Inc. (April 2010), Mr. Chambers served as Vice President, Medtronic Commercial Business Development, AF Solutions following the acquisition of Ablation Frontiers by Medtronic Inc, 5 Feb 2009. Mr. Chambers joined Ablation Frontiers in February 2006 as Vice President of Global Sales & Marketing and was fully responsible for building the commercial strategic plan, executing against the plan and delivering a viable and compelling therapeutic value proposition. Prior to this Mr Chambers worked for EV3, (Peripheral Endovascular), and 14 years with Guidant Corporation, (Cardiac Rhythm Management & Vascular Intervention).
Trent Reutiman, Global Vice President of Marketing
Bachelor of Science, Business, Colorado State University
Master of Business Administration – University of California, Irvine
Mr. Reutiman has over 18 years in the medical device industry in various leadership positions. Mr. Reutiman joined ROX Medical in 2006. Prior to that, Mr. Reutiman was Vice President of Sales for OmniSonics Medical Technologies where he built a commercial sales organization. Beginning in 2000 Mr. Reutiman worked for RITA Medical Systems, Inc where he was Vice President of US Sales and then served as Vice President of Sales & Marketing. RITA completed a successful IPO in 2000, Merged in 2005 with Horizon Medical Products and was acquired in January of 2007 by Angiodynamics. His experience prior to that was in various sales and sales management positions for Cordis, a Johnson & Johnson Company, and Guidant/Cardio Thoraic Systems, Inc.
Helene Lamielle, Vice President of CA/QA/RA
Medical Degree from Lyon, France
Master in Business Administration from University of California, Irvine
Ms. Lamielle has 20 years of experience in the medical device industry including responsibilities in Research and Development, Clinical and Regulatory Affairs. She joined ROX Medical in 2008. Prior to ROX Medical, Ms Lamielle was with Glaukos Corporation as the Vice President of Regulatory, Quality Assurance and Clinical Affairs. Her career includes tenures at Staar Surgical as Chief Scientific Officer, Bausch & Lomb Surgical as VP of Scientific Affairs, and Chiron Vision as the European Scientific Director. An experienced senior professional, she is well-versed in both US and EU clinical trials and in guiding products through the regulatory process to approvals.